Electroconvulsive Therapy in a Left Ventricular Assist Device Recipient With Treatment-Resistant Depression.

Depression and heart failure are highly comorbid, with up to 35% of heart failure patients suffering from comorbid depression. Left ventricular assist devices (LVADs) serve as a major lifeline for patients with heart failure; however, despite the drastic improvement in cardiac function following LVAD implantation, up to 24% of LVAD recipients suffer from depression. Depression management in LVAD recipients is often complicated by the recipient's increased risk for antidepressant side effects, adverse drug reactions, and inability to safely receive certain interventional psychiatry therapies, as the LVAD is either a relative or absolute contraindication.

A single centre intercomparison between commercial treatment planning systems for Y radioembolization using virtual and experimental phantoms.

Introduction: Dedicated Treatment Planning Systems (TPSs) were developed to personalize Y-transarterial radioembolization. This study evaluated the agreement among four commercial TPSs assessing volumes of interest (VOIs) volumes and dose metrics.

Methods: A homogeneous (EH) and an anthropomorphic phantom with hot and cold inserts (EA) filled with Tc-pertechnetate were acquired with a SPECT/CT scanner.

The Role of Decision-Making Capacity in Gathering Collateral Information.

AbstractPsychiatric disorders usually do not have characteristic physical exam findings, imaging, or lab values. Psychiatrists therefore diagnose and treat patients largely based on reported or observed behavior, which makes collateral information from a patient's close contacts especially pertinent to an accurate diagnosis. The American Psychiatric Association considers communication with patients' supports a best practice when the patient provides informed consent or does not object to the communication.

A novel tool for predicting the dose distribution of non-sealed Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patients.

Background: High-dose rate brachytherapy using a non-sealed Rhenium resin ( Re) is a recently approved treatment option for non-melanoma skin cancer (NMSC). The treatment goal is to deliver a personalized absorbed dose to the deepest point of neoplastic infiltration corresponding to the minimal target dose. The treatment consists of the application of a Re-based resin over a plastic foil placed on the target skin surface.

A novel figure of merit to investigate Ga PET/CT image quality based on patient weight and lesion size using Q.Clear reconstruction algorithm: A phantom study.

Introduction: Q.Clear is a Bayesian penalised-likelihood algorithm that uses a β-value for positron emission tomography(PET)/computed tomography(CT) image reconstruction(IR). Our study proposes a novel figure of merit, named CRBV, to compare the Q.